Ardelyx Statistics
NASDAQ: ARDXHealthcareBiotechnologyUSD
3.26-0.05 (-1.51%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Ardelyx by the numbers
Ardelyx has a market capitalization of $841.7 million based on 258.19M shares outstanding. With trailing EPS of $-0.23, Ardelyx is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.1% below its 50-day average and 41.9% below its 200-day average.
Average daily trading volume is 4.08M shares, or about $13.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARDX valuation vs. peer median
| Metric | ARDX | Peer median | Difference |
|---|---|---|---|
| Market cap | $841.69M | $857.19M | -2% |
| Avg. volume | 4.08M | 857.24K | +376% |
Peer median across 8 companies: SLBT, AVBP, GLUE, OBX, ODTX, SANA, CRVS, JBIO.
Valuation
- Market cap
- $841.69M
- Forward P/E
- 11.22
- EPS (TTM)
- $-0.23
- Shares outstanding
- 258.19M
Price and trading
- Previous close
- 3.31
- Open
- 3.26
- Day range
- 3.22 – 3.35
- 52-week range
- 3.22 – 8.40
- 52-week change
- -36.94%
- Beta
- —
- Volume
- 5.39M
- Average volume
- 4.08M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 841.69M
- Forward Pe
- 11.22
- Eps
- -0.23
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.40
- Week52 Low
- 3.22
- Avg Volume
- 4.08M
- Shares Outstanding
- 258.19M
- Ma50
- 3.89
- Ma200
- 5.61
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -61.19%
- Pct From52w Low
- 1.24%